Table 1.
Preoperative, operative and postoperative data of patients included in the study.
| Variable | Total Series (n = 40) | TURP (n = 23) | HoLEP (n = 17) | p-Value |
|---|---|---|---|---|
| Preoperative Data | ||||
| Age, years, median (IQR) | 71 (11) | 73 (13) | 71 (9) | 0.48 |
| Months since BPE surgery, median (IQR) | 41 (38) | 43 (35) | 37 (39) | 0.26 |
| Previous radiation therapy, n (%) | 10 (25) | 8 (34.8) | 2 (11.8) | 0.14 |
| Androgen deprivation therapy, n (%) | 3 (7.9) | 2 (8.7) | 1 (6.7) | 0.45 |
| Bladder neck stricture, n (%) | 11 (27.5) | 8 (34.8) | 2 (11.8) | 0.14 |
| OAB symptoms, n (%) | 10 (25) | 7 (30.4) | 3 (17.6) | 0.24 |
| 24 h pad count, PPD, median (IQR) | 5 (2.5) | 5 (3) | 5 (1) | 0.98 |
| 24 h pad test, mL, median (IQR) | 500 (350) | 648 (650) | 500 (340) | 0.62 |
| Mild incontinence (<400 mL), n (%) | 13 (32.5) | 7 (30.4) | 6 (35.3) | 0.87 |
| Moderate incontinence (400–800 mL), n (%) | 16 (40) | 10 (43.5) | 6 (35.3) | |
| Severe incontinence (>800 mL), n (%) | 11 (27.5) | 6 (26.1) | 5 (29.5) | |
| Operative Data | ||||
| Operative time, min, median (IQR) | 65 (18) | 60 (15) | 67 (29) | 0.26 |
| Intraoperative complication, n (%) | 0 (0) | 0 (0) | 0 (0) | 1 |
| Postoperative Data | ||||
| Months after ATOMS, median (IQR) | 33 (30.5) | 33 (43) | 30 (26) | 0.92 |
| Any postoperative complications (1), n (%) | 7 (17.5) | 3 (13) | 4 (23.5) | 0.43 |
| Grade I (1), n (%) | 2 (5) | 2 (8.7) | 0 (0) | |
| Grade II (1), n (%) | 5 (12.5) | 1 (4.3) | 4 (23.5) | |
| Surgical revision (2), n (%) | 3 (7.5) | 1 (4.3) | 2 (11.8) | 0.56 |
| Device explant (2), n (%) | 2 (5) | 0 (0) | 2 (11.8) | 0.17 |
| Analgesics required (3), n (%) | 2 (5) | 0 (0) | 2 (10.5) | 1 |
| De novo OAB symptoms, n (%) | 2 (5) | 1 (4.3) | 1 (5.9) | 1 |
| Total filling volume, mL, median (IQR) | 15 (9.5) | 15 (12) | 16 (13) | 0.6 |
| Number of fillings, median (IQR) | 3 (2.5) | 3 (2) | 3 (4) | 0.72 |
| Dryness (pad test ≤ 20 mL), n (%) | 32 (80) | 18 (78.3) | 14 (82.3) | 1 |
| Total continence (zero leakage), n (%) | 18 (45) | 10 (43.5) | 8 (47) | 0.82 |
| 24 h pad test, mL, median (IQR) (4) | 20 (89) | 40 (90) | 10 (89) | 0.56 |
| PGI-I = 1–3 (at least better), n (%) (4) | 37 (92.5) | 22 (95.7) | 15 (88.2) | 0.56 |
(1) According to Clavien–Dindo classification within the first 3 postoperative months; (2) any time during follow-up; (3) analgesic needs for more than one month postoperatively; (4) evaluated at last follow-up visit; IQR, interquartile range; BPE, benign prostatic enlargement; OAB, overactive bladder; PPD, pads per day; PGI-I, Patient Global Impression of Improvement.